Antisense Therapeutics Ltd
ASX:ANP

Watchlist Manager
Antisense Therapeutics Ltd Logo
Antisense Therapeutics Ltd
ASX:ANP
Watchlist
Price: 0.084 AUD 1.2% Market Closed
Market Cap: 75.7m AUD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ANP.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ANP Intrinsic Value
Not Available
Base Case Scenario
Compare ANP to

Fundamental Analysis

Antisense Therapeutics Ltd
ASX:ANP
AU
Pharmaceuticals
Market Cap
75.7m AUD
IPO
Dec 20, 2001
AU
Pharmaceuticals
Market Cap
75.7m AUD
IPO
Dec 20, 2001
Price
AU$false
EPS
AU$false
Antisense Therapeutics Ltd
Company Overview
Loading...
Contacts
Loading...
How do you feel about ANP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Antisense Therapeutics Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Antisense Therapeutics Ltd

Current Assets 12.7m
Cash & Short-Term Investments 11m
Receivables 1.7m
Other Current Assets 66.5k
Non-Current Assets 150.8k
PP&E 150.8k
Efficiency

Free Cash Flow Analysis
Antisense Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Antisense Therapeutics Ltd

Revenue
384.9k AUD
Operating Expenses
-11.8m AUD
Operating Income
-11.4m AUD
Other Expenses
380 AUD
Net Income
-11.4m AUD
Fundamental Scores

ANP Profitability Score
Profitability Due Diligence

Antisense Therapeutics Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Declining ROE
26/100
Profitability
Score

Antisense Therapeutics Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

ANP Solvency Score
Solvency Due Diligence

Antisense Therapeutics Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
79/100
Solvency
Score

Antisense Therapeutics Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANP Price Targets Summary
Antisense Therapeutics Ltd

There are no price targets for ANP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Antisense Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ANP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ANP Insider Trading
Buy and sell transactions by insiders